Suzetrigine – A Novel FDA‐Approved Analgesic – Opportunities, Challenges and Future Perspectives: A Perspective Review

Suzetrigine is considered an alternative option in the realm of acute pain management. Due to its selectivity, this medication does not interfere with other local anesthetics. Moreover, this selectivity also constrains this medication to act on other receptors, thus possessing the least amount of adverse effects. Although Suzetrigine created many opportunities for research in the field of pain management, but also opened a door for many uncertainties that cannot be ignored.